BIIB

BIIB

Biogen Inc
Biotechnology
$172.97 -2.34% As of Apr 11, 6:05 AM
Loading chart...
Interactive chart powered by TradingView

Technical Analysis

Traders Watch BIIB Squeeze Closely at $172.97

Neutral
Apr 11, 2026 at 6:05 AM • $172.97 (-2.34%)

The stock of Biogen Inc (BIIB) dropped 2.34% to close at $172.97 on April 11.

Key indicators suggest a bearish bias:

Moving Averages The stock trades below its 9-day EMA ($178.23) with the 21-day ($181.44) acting as overhead resistance.
Momentum RSI at 39.9 is neutral but improving. MACD is bearish (-2.82 vs signal -1.79).
Volatility A 20-day TTM Squeeze suggests volatility is coiled and a breakout may be imminent.

The $172.35-$191.54 range defines near-term boundaries.

BIIB Volatility Compresses at $172.97, Breakout Watch

Neutral
Apr 10, 2026 at 9:01 PM • $172.97 (-2.34%)

Squeeze Play: BIIB Preps for Breakout at $177.11

Neutral
Apr 9, 2026 at 9:01 PM • $177.11 (-1.56%)

BIIB Bands Narrow to Multi-Week Lows at $179.90

Neutral
Apr 8, 2026 at 9:01 PM • $179.90 (+2.45%)

BIIB Bands Narrow to Multi-Week Lows at $175.61

Neutral
Apr 7, 2026 at 9:01 PM • $175.61 (+1.90%)
Systematic technical analysis • Updated daily after market close
Exclusive Offer

Get Trade Alerts

Receive disciplined options trade ideas with entries, targets & risk management.

Use code:
HEADSTART50
50% off your first month
Claim Offer Try Scanner

Market Summary

Current Price $172.97
Daily Change -2.34%
Sentiment Neutral
Sector Biotechnology
Last Updated Apr 11

Related Stocks

ABBV
ABBV
AbbVie Inc
AMGN
AMGN
Amgen Inc
MRNA
MRNA
Moderna Inc
REGN
REGN
Regeneron Pharmaceuticals Inc
VRTX
VRTX
Vertex Pharmaceuticals Inc
Disclaimer: This analysis is for educational purposes only. Options trading involves substantial risk. Past performance does not guarantee future results.